This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1018. The goal of this clinical trial is to confirm the theraputic effect of selective lymph node dissection for cT1N0M0 invasive non-small cell lung cancer with CTR\>0.5 located in the apical segment. The main questions it aims to answer are: The 5-year overall survival of patients having cT1N0M0 invasive non-small cell lung cancer with CTR\>0.5 located in the apical segment; The post-operative lymph node metastasis and recurrence-free survival. Participants will receive selective lymph node dissection as the surgical procedure.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
634
For patients with NSCLC with CTR\>0.5 located in the apical segment, the inferior mediastinal lymph node was not need to dissected
Chaoqiang Deng
Shanghai, Please Select, China
RECRUITING5-year overall survival
The event is defined as the death due to any causes.
Time frame: 5 years
Lymph node metastasis
the lymph node metastasis situation of each pathological subtype
Time frame: 5 years
5-year recurrence-free survival
The event is defined as the tumor recurrence.
Time frame: 5 years
The accuracy of frozen section
The concordance of frozen section and final pathological diagnosis for invasiveness
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.